盐酸氨溴索与溴己新治疗急性发作期慢性阻塞性肺疾病的疗效观察

侯丽英

（陕西省渭南市合阳县中医医院，陕西 渭南，715399）

浏览次数：105次 下载次数：427次

摘要：

目的 探讨盐酸氨溴索与溴己新在治疗急性发作期慢性阻塞性肺疾病（COPD）的疗效。方法 收集我院88例COPD急性发作期患者，随机分为两组，各44例。两组患者均给予相同的对症支持治疗，试验组患者给予盐酸氨溴索治疗，对照组患者给予溴己新治疗。记录两组患者的治疗总有效率、治疗前后两组患者的呼吸频率、氧饱和度及用力肺活量。结果 试验组患者治疗总有效率高于对照组（P<0.05）。治疗后，试验组患者氧饱和度、呼吸频率及用力肺活量明显优于对照组患者（P<0.05）。结论 盐酸氨溴索治疗COPD急性发作期患者优于溴己新，有效率更高，安全性较高。

关键词：盐酸氨溴索；溴己新；慢性阻塞性肺疾病；急性发作期

中图分类号：R563.9文献标志码：A文章编号：2096-1413(2017)16-0030-02

Efficacy of ambroxol hydrochloride and bromhexine in the treatment of acute exacerbation of chronic obstructive pulmonary disease
HOU Li-ying
(TCM Hospital of Heyang County, Weinan 715399, China)

ABSTRACT: Objective To investigate the efficacy of ambroxol hydrochloride and bromhexine in the treatment of acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods A total of 88 patients with acute exacerbation of COPD in our hospital were enrolled and divided into two groups, with 44 cases in each group. Both groups were given the same symptomatic and supportive treatment. The experimental group was treated with ambroxol hydrochloride, and the control group received bromhexidine. The total effective rate of the treatment, respiratory rate, oxygen saturation and forced vital capacity before and after treatment were analyzed. Results The effective rate of the experimental group was higher than that of the control group (P<0.05). After treatment, the oxygen saturation, respiratory rate and forced vital capacity of the experimental group were significantly better than those of the control group (P<0.05). Conclusion Ambroxol hydrochloride has better efficacy compared wish bromhexine in treating patients with acute exacerbation of COPD, with more efficient and high security.
KEYWORDS: ambroxol hydrochloride; bromhexine; chronic obstructive pulmonary disease; acute exacerbation

参考文献：
[1] 喻樊,徐芳芳.盐酸氨溴索2种含量测定方法的比较[J].抗感染药 学,2013,10(2):107-109.
[2] 闫辉,张敬晶.盐酸氨溴索临床研究进展[J].现代中西医结合杂志,2011,20(22):2856-2858.
[3] 徐永谊,陈怡禄,梁小丽.盐酸氨溴索注射液在儿科呼吸系统疾病中的合理应用[J].中国医药导报,2009,6(5):155-156.
[4] 王波,龙敏,程伟,等.哌拉西林/舒巴坦联合盐酸氨溴索治疗2型糖尿病肺部感染患者的疗效分析[J].中华医院感染学杂志,2015,25(10):2222-2224.
[5] 苏兵.盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效观察[J].医学理论与实践,2015,28(8):1032-1033.
[6] 龙仁贵.盐酸氨溴索治疗慢性阻塞性肺疾病疗效及对患者肺功能与免疫功能的影响[J].海南医学院学报,2014,20(9):1193-1195.
[7] 刘博,张睿,彭伟,等.盐酸氨溴索辅助治疗对慢性阻塞性肺疾病伴肺部感染患者肺功能和血气指标的影响[J].疑难病杂志,2016,15(10):1020-1023.
[8] 韩颜,陈泊颖,苏娜,等.盐酸氨溴索平衡溶解度和表观油水分配系数的测定[J].药物评价研究,2016,39(4):615-618.